News

Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
This was the stock's third consecutive day of losses.
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $482.4, with a high estimate of $567.00 and a low estimate of $420.00. This current average ...
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
The stock's fall snapped a three-day winning streak.
Vertex Pharmaceuticals to lay off 125 Rhode Island workers. What we know.
Vertex Pharmaceuticals is laying off 125 employees and consolidating their Rhode Island buildings after a failed diabetes ...
Cystic Fibrosis Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The leading Cystic Fibrosis Companies such as Verona Pharma, Armata Pharmaceuticals, 4D Molecular Therapeutics, Spirovant ...
Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $455.45, denoting a -1% move from the preceding trading day.
Boston drugmaker Vertex slashes Providence workforce, shrinks real estate following trial failure
Vertex Pharmaceuticals is laying off workers and consolidating its real estate footprint in Rhode Island after ending a ...
Zacks Investment Research on MSN13d
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Vertex Pharmaceuticals lays off 125 workers in RI
According to a Worker Adjustment Retraining Notification written by Vertex to the R.I. Department of Labor and Training, ...